Similar articles

• Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.

  Garcia-Carrasco M, Mendoza-Pinto C, Sandoval-Cruz M, Soto-Vega E, Beltran-Castillo A, Jimenez-Hernandez M, Graillet D, Gonzalez L, Rojas-Rodriguez J, Pineda-Almazana A, Zamudio-Huerta L, Lopez-Colombo A. Garcia-Carrasco M, et al. Lupus. 2010 Feb;19(2):213-9. doi: 10.1177/0961203309351541. Epub 2009 Dec 4. Lupus. 2010. PMID: 19965944
• Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy.

  Camous L, Melander C, Vallet M, Squalli T, Knebelmann B, Noël LH, Fakhouri F. Camous L, et al. Am J Kidney Dis. 2008 Aug;52(2):346-52. doi: 10.1053/j.ajkd.2008.03.036. Epub 2008 Jun 24. Am J Kidney Dis. 2008. PMID: 18572292
• Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus.

  Suzuki K, Nagasawa H, Kameda H, Amano K, Kondo T, Itoyama S, Tanaka Y, Takeuchi T. Suzuki K, et al. Rheumatology (Oxford). 2009 Feb;48(2):198-9. doi: 10.1093/rheumatology/ken421. Epub 2008 Nov 23. Rheumatology (Oxford). 2009. PMID: 19029134 No abstract available.
• Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.

  Lim SW, Gillis D, Smith W, Hissaria P, Greville H, Peh CA. Lim SW, et al. Intern Med J. 2006 Apr;36(4):260-2. doi: 10.1111/j.1445-5994.2006.01055.x. Intern Med J. 2006. PMID: 16640745 Review.
• Rituximab for myasthenia gravis: three case reports and review of the literature.

  Stieglbauer K, Topakian R, Schäffer V, Aichner FT. Stieglbauer K, et al. J Neurol Sci. 2009 May 15;280(1-2):120-2. doi: 10.1016/j.jns.2009.02.357. Epub 2009 Mar 9. J Neurol Sci. 2009. PMID: 19272616 Review.